Jennifer Downs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jennifer Downs has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Abigail Evans
Radiology Department, University Hospitals Dorset NHS Foundation Trust, Poole, UK
1 shared publication- Amit Parekh
Radiology Department, University Hospitals Dorset NHS Foundation Trust, Poole, UK
1 shared publication D E Gyorki
Division of Cancer Surgery Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
1 shared publicationD. Speakman
Division of Cancer Surgery Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
1 shared publication- David E. Gyorki
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia
1 shared publication M. J. Wilkinson
Division of Cancer Surgery Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Endocrinology
- Vol. 2025 (1) , 3922886
Factors Associated With Successful Parathyroid Adenoma Localisation in Sestamibi Study—Can Change in Serum Calcium Be a Useful Indicator?
Objective: Primary hyperparathyroidism can be cured by the successful removal of the culpable parathyroid adenoma. Successful localisation allows the specialist surgeon to perform safer and more cost‐effective focused excisions rather than exploratory surgery. This study aims to identify possible factors that predict successful adenoma localisation using technetium99m–sestamibi. Design, Patients and Measurements: Retrospective analysis of 159 patients undergoing parathyroid localisation with technetium99m–sestamibi SPECT/CT. Patients were classified as successful or unsuccessful localisation when compared to the surgical site of a proven adenoma following successful parathyroidectomy. Preoperative and postoperative serum parathyroid hormone (PTH), calcium and 25‐hydroxyvitamin D levels and pathological size of the parathyroid adenoma were recorded. Results: Larger specimen volume, weight and higher preoperative PTHs were strongly associated with successful localisation. The percentage change in serum calcium (calculated as the difference between pre‐ and post‐op calcium) was also strongly associated with successful localisation. Higher preoperative serum calcium (> 2.85 mmol/L) was also associated with successful localisation although with a reduced statistical significance. Seventy percent of patients in our cohort underwent parathyroidectomy with a serum calcium < 2.85 mmol/L, of which 92% had pathologically confirmed adenomas and 67% had successful localisation with sestamibi. Conclusion: The serum PTH and change in serum calcium were most strongly associated with successful localisation. The degree of hypercalcaemia was also associated with successful localisation but without as strong an association when compared to the change in calcium. Several factors influence the degree of hypercalcaemia in patients with primary hyperparathyroidism including parathyroid adenoma size, 25‐hydroxyvitamin D status and the individual’s baseline calcium set point. Historic information (if available) on the patient’s individual baseline set point prior to developing primary hyperparathyroidism, and subsequent elevation when primary hyperparathyroidism has developed, could aid decision‐making for clinicians when deciding on parathyroidectomy.
- 1 January 2025
- Published by Wiley in International Journal of Endocrinology
- Vol. 2025 (1) , 3922886
Open AccessFactors Associated With Successful Parathyroid Adenoma Localisation in Sestamibi Study—Can Change in Serum Calcium Be a Useful Indicator?
Objective: Primary hyperparathyroidism can be cured by the successful removal of the culpable parathyroid adenoma. Successful localisation allows the specialist surgeon to perform safer and more cost‐effective focused excisions rather than exploratory surgery. This study aims to identify possible factors that predict successful adenoma localisation using technetium99m–sestamibi. Design, Patients and Measurements: Retrospective analysis of 159 patients undergoing parathyroid localisation with technetium99m–sestamibi SPECT/CT. Patients were classified as successful or unsuccessful localisation when compared to the surgical site of a proven adenoma following successful parathyroidectomy. Preoperative and postoperative serum parathyroid hormone (PTH), calcium and 25‐hydroxyvitamin D levels and pathological size of the parathyroid adenoma were recorded. Results: Larger specimen volume, weight and higher preoperative PTHs were strongly associated with successful localisation. The percentage change in serum calcium (calculated as the difference between pre‐ and post‐op calcium) was also strongly associated with successful localisation. Higher preoperative serum calcium (> 2.85 mmol/L) was also associated with successful localisation although with a reduced statistical significance. Seventy percent of patients in our cohort underwent parathyroidectomy with a serum calcium < 2.85 mmol/L, of which 92% had pathologically confirmed adenomas and 67% had successful localisation with sestamibi. Conclusion: The serum PTH and change in serum calcium were most strongly associated with successful localisation. The degree of hypercalcaemia was also associated with successful localisation but without as strong an association when compared to the change in calcium. Several factors influence the degree of hypercalcaemia in patients with primary hyperparathyroidism including parathyroid adenoma size, 25‐hydroxyvitamin D status and the individual’s baseline calcium set point. Historic information (if available) on the patient’s individual baseline set point prior to developing primary hyperparathyroidism, and subsequent elevation when primary hyperparathyroidism has developed, could aid decision‐making for clinicians when deciding on parathyroidectomy.
- Open Access
- 14 May 2020
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 107 (8) , e248
Providing cancer surgery in the COVID-19 crisis
- 14 May 2020
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 107 (8) , e248
Open AccessProviding cancer surgery in the COVID-19 crisis
- Open Access
- 18 October 2019
- Published by Taylor & Francis in Melanoma Management
- Vol. 6 (3) , MMT24
An Evidence-Based Approach to Positive Sentinel Node Disease: Should we ever do a Completion Node Dissection?
Management of later stage melanoma has undergone significant changes. Sentinel node biopsy has long been an accepted method of staging, but two recent randomized-controlled trials have provided an ...
- 18 October 2019
- Published by Taylor & Francis in Melanoma Management
- Vol. 6 (3) , MMT24
Open AccessAn Evidence-Based Approach to Positive Sentinel Node Disease: Should we ever do a Completion Node Dissection?
Management of later stage melanoma has undergone significant changes. Sentinel node biopsy has long been an accepted method of staging, but two recent randomized-controlled trials have provided an ...